Drug Shortage Report for SANDOZ ATORVASTATIN

Last updated on 2019-01-16 History
Report ID 62926
Drug Identification Number 02324970
Brand name SANDOZ ATORVASTATIN
Common or Proper name ATORVASTATIN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) ATORVASTATIN
Strength(s) 80MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 3 X 10 BLISTERS
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-09-27
Estimated end date 2019-01-14
Actual end date 2019-01-14
Shortage status Resolved
Updated date 2019-01-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2019-01-16 French Compare
v15 2019-01-16 English Compare
v14 2018-12-24 French Compare
v13 2018-12-24 English Compare
v12 2018-12-13 French Compare
v11 2018-12-13 English Compare
v10 2018-11-26 French Compare
v9 2018-11-26 English Compare
v8 2018-11-06 French Compare
v7 2018-11-06 English Compare
v6 2018-11-04 French Compare
v5 2018-11-04 English Compare
v4 2018-10-20 French Compare
v3 2018-10-20 English Compare
v2 2018-10-02 French Compare
v1 2018-10-02 English Compare

Showing 1 to 16 of 16